Search - tctmd.com

Displaying 1 - 16 of 16

Sort: Relevancy | Date

Presentation TCT 2014

Cost-effectiveness Analysis Of Left Atrial Appendage Occlusion Device Compared With 7 Oral Anticoagulants For Stroke Prevention In Atrial Fibrillation

Presenter: Vivian Lee

September 16, 2014

Presentation TCT 2014

TCT 170: Cost-effectiveness Analysis of a Left Atrial Appendage Occlusion Device Compared with 7 Oral Anticoagulants for Stroke Prevention in Atrial Fibrillation

Presenter: Saibal Kar, Bushra S Rana, Jai-Wun Park, Vivian Lee

September 15, 2014

Presentation TCT 2014

AF Ablation: Stand-Alone and in Conjunction with LAA Closure

Presenter: Shephal Doshi, Gregg W. Stone, Steven R. Bailey, Vivek Y. Reddy

September 15, 2014

Presentation TCT 2014

Watchman I: First Report of the 5-Year PROTECT-AF and Extended PREVAIL Results

Presenter: Shephal Doshi, Gregg W. Stone, Steven R. Bailey, Vivek Y. Reddy

September 15, 2014

News Conference News TCT 2014

LAA Closure Edges Out Medical Therapy for Cost-effectiveness in AF

September 14, 2014

Presentation TCT 2014

Watchman Nightmare Case and Teaching Moment #2: Improper Device Sizing with Embolization

Presenter: Josep Rodés-Cabau, Carlos E. Ruiz, Vivek Y. Reddy

September 13, 2014

Presentation TCT 2013

A Cost Benefit Analysis of Left Atrial Appendage Closure Versus Warfarin for Stroke Prevention in Atrial Fibrillation

Presenter: Vivek Y. Reddy

October 29, 2013

Presentation TCT 2013

Pro(2)

Presenter: Vivek Reddy

October 28, 2013

Presentation TCT 2013

LAA Closure in Combination with Ablation: Rationale and Results

Presenter: Vivek Reddy

October 27, 2013

Presentation TCT 2013

First In-Vivo Evaluation of the Ultrasept Left Atrial Appendage Closure Device

Presenter: Yanping Cheng, Gerard Conditt, Genghua Yi, Alyssa Wagner, Patricia Mount, Armando Tellez, Serge Rousselle, Greg Kaluza, Juan Granada

January 31, 2013

Presentation TCT 2013

Cost-effectiveness Of Transcatheter Left Atrial Appendage Occlusion Compared With 5 Alternative Anticoagulation Strategies For Stroke Prevention In Atrial Fibrillation: A Markov...

Presenter: Bryan Yan, Chow Innes, Yat Yin Lam, Vivian Lee, Cheuk Man Yu

January 31, 2013

Presentation TCT 2012

Will Transcatheter Left Atrial Appendage Closure Transform Management of Atrial Fibrillation?

Presenter: Vivek Reddy

October 25, 2012

Presentation TCT 2012

Tough Call During an LAA Occlusion

Presenter: Vivek Reddy

October 24, 2012

Presentation TCT 2012

The New Fourth-Generation WATCHMAN (BSC-Atritech): Device Design and Results of the EVOLVE Trial

Presenter: Vivek Reddy

October 23, 2012

Presentation TCT 2012

Quality-of-Life and Cost-Effectiveness After LAA Closure

Presenter: Vivek Reddy

October 23, 2012

Presentation TCT 2012

ICE Guidance for LAA Closure: Advantages and Limitations

Presenter: Vivek Reddy

October 23, 2012

Advertisement

Cost-effectiveness Analysis Of Left Atrial Appendage Occlusion Device Compared With 7 Oral Anticoagulants For Stroke Prevention In Atrial Fibrillation

TCT 170: Cost-effectiveness Analysis of a Left Atrial Appendage Occlusion Device Compared with 7 Oral Anticoagulants for Stroke Prevention in Atrial Fibrillation

AF Ablation: Stand-Alone and in Conjunction with LAA Closure

Watchman I: First Report of the 5-Year PROTECT-AF and Extended PREVAIL Results

LAA Closure Edges Out Medical Therapy for Cost-effectiveness in AF

Watchman Nightmare Case and Teaching Moment #2: Improper Device Sizing with Embolization

A Cost Benefit Analysis of Left Atrial Appendage Closure Versus Warfarin for Stroke Prevention in Atrial Fibrillation

Pro(2)

LAA Closure in Combination with Ablation: Rationale and Results

First In-Vivo Evaluation of the Ultrasept Left Atrial Appendage Closure Device

Cost-effectiveness Of Transcatheter Left Atrial Appendage Occlusion Compared With 5 Alternative Anticoagulation Strategies For Stroke Prevention In Atrial Fibrillation: A Markov...

Will Transcatheter Left Atrial Appendage Closure Transform Management of Atrial Fibrillation?

Tough Call During an LAA Occlusion

The New Fourth-Generation WATCHMAN (BSC-Atritech): Device Design and Results of the EVOLVE Trial

Quality-of-Life and Cost-Effectiveness After LAA Closure

ICE Guidance for LAA Closure: Advantages and Limitations

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content